What Medacta USA, Inc. does

Medacta USA, Inc. is the United States subsidiary of Medacta Group SA, a Swiss-founded global orthopedic medical device company established in 1999 by Dr. Alberto Siccardi. The company designs, manufactures, and markets implants and surgical technologies for hip, knee, and shoulder replacement, spine surgery, and sports medicine, serving orthopedic surgeons, hospitals, and ambulatory surgical centers in more than 60 countries. Its technology stack centers on three differentiated platforms: the NextAR augmented-reality surgical system (the first FDA-cleared AR platform for total knee replacement, now extended to shoulder and spine), patient-matched 3D-printed surgical guides (MySpine, MyKnee, MyShoulder) built from CT/MRI-based planning, and proprietary implant systems such as the AMIS minimally invasive hip technique (over 500,000 procedures performed worldwide) and the GMK Sphere/SpheriKA ball-in-socket knee platform optimized for kinematic alignment.

The business operates a direct enterprise sales model, selling hardware (implants, instruments, navigation systems) to hospitals and surgical centers at quote-based pricing negotiated per institution, with no subscription or SaaS component. The US operations are run from a 274-person office in Franklin, Tennessee, with US-based sales coverage of orthopedic and spine markets, augmented by the March 2025 acquisition of Parcus Medical for sports medicine expansion. Global group-level FY2025 revenue reached EUR 683.8m with 18.5% constant-currency growth and a 27.9% Adjusted EBITDA margin, reflecting strong double-digit scale-up driven by geographic expansion, new product launches, and acquisitions. Medacta is publicly listed on the SIX Swiss Exchange (ticker: MOVE) since April 2019, with the founding Siccardi family retaining approximately 69.45% control, and continues to operate as a multi-generational family-led enterprise with a global medical education backbone (M.O.R.E. Institute, Medacta TV) used as a primary demand-generation channel.

Name

Medacta USA, Inc.

Legal name

Medacta USA, Inc.

Website

https://medacta.us.com

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

251–500 employees

Short description

Medacta USA, Inc. is the U.S. subsidiary of Swiss orthopedic device maker Medacta Group, selling hip, knee, shoulder, spine, and sports medicine implants plus the NextAR augmented-reality surgical platform to hospitals and surgical centers across more than 60 countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Castel San Pietro

HQ country

Switzerland

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Orthopedic Implants and Surgical Instruments: Medacta generates revenue through the sale of orthopedic implants for hip, knee, and shoulder replacement, spine surgery products, and sports medicine solutions. The company also sells surgical instruments and enabling technologies including navigation systems and patient-matched solutions.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Medacta USA, Inc. designs, manufactures, and sells orthopedic implants, surgical instruments, and enabling technologies for hip, knee, shoulder, and spine procedures. The portfolio includes the AMIS minimally invasive hip technique, GMK knee systems, Medacta Shoulder System, M.U.S.T. spinal fixation, MySpine patient-matched guides, and the NextAR augmented reality surgical platform. The company also provides surgeon education through the M.O.R.E. Institute.

Product overview

Medacta USA, Inc. offers a comprehensive orthopedic and spine surgery portfolio organized around four core areas: Hip (AMIS minimally invasive technique, femoral stems including AMIStem and Quadra, acetabular systems including Versafitcup and Mpact, and MyHip planning), Knee (GMK knee systems including GMK Sphere and GMK Spherika for kinematic alignment, patient-matched MyKnee technology, MOTO partial knee platform, and revision solutions), Shoulder (Medacta Shoulder System with MyShoulder personalization), and Spine (M.U.S.T. fixation systems, MectaLIF fusion, Mecta-C cervical, MySpine patient-matched guides). The portfolio is enabled by technology platforms including NextAR augmented reality surgical system, M.O.R.E. Institute medical education, MySolutions personalized ecosystem, and single-use instruments (GMK Efficiency). Founded in 1999 and headquartered in Switzerland with U.S. presence in Franklin, TN, Medacta serves global markets through continuous innovation in minimally invasive techniques and personalized solutions.

Differentiator

Problem solved

Functional benefit

Brands

• M.O.R.E. Institute: Global medical education platform providing personalized and structured education programs for surgeons
• AMIS
• GMK Sphere
• MySpine
• MyKnee
• NextAR
• Medacta TV
• Medacta for Life Foundation
• MOTO Platform
• GMK Efficiency
• Versafitcup
• MiniMAX

Products and services

• NextAR Surgical Platform FDA-cleared augmented reality-based surgical platform for total knee replacement, using patient-specific data and 3D planning tools with AR visualization for personalized surgical guidance. For orthopedic surgeons and hospitals.
• NextAR Shoulder Augmented reality surgical application for shoulder replacement, expanded to glenoid deformity and revision cases. For orthopedic surgeons performing shoulder arthroplasty.
• NextAR Spine Augmented reality platform for spine surgery with 3D planning tools and real-time surgical guidance. For spine surgeons.
• NextAR Rod Optimizer Disruptive technology for rod management in spine surgery. For spine surgeons performing complex procedures.
• GMK Spherika Knee implant optimized for Kinematic Alignment (KA) technique with Ball-in-Socket design, designed to restore natural knee alignment. For orthopedic surgeons performing total knee replacement.
• GMK Sphere Total knee replacement system with Ball-in-Socket design, awarded 5A ODEP rating, 10+ years of clinical success with kinematic alignment. Over 100,000 implants worldwide.
• GMK Primary Total knee replacement system awarded 3A* ODEP rating confirming excellent survival rate. For orthopedic surgeons performing primary total knee replacement.
• GMK Revision Knee revision system for complex revision cases. For orthopedic surgeons performing knee revision procedures.
• GMK Hinge Hinge knee implant system for revision and complex primary procedures. For orthopedic surgeons managing complex knee cases.
• MOTO Platform Partial knee replacement platform including MOTO Medial, MOTO Lateral, and MOTO PFJ for unicompartmental knee procedures. For orthopedic surgeons performing partial knee replacement.
• AMIS (Anterior Minimally Invasive Surgery) Minimally invasive hip replacement technique with specialized instruments and implants, with over 500,000 procedures performed worldwide. For orthopedic surgeons performing hip replacement.
• AMIStem Cementless femoral stem for hip replacement, with AMIStem-P for primary and AMIStem-H for hemiarthroplasty, awarded 5A ODEP rating. For orthopedic surgeons performing hip replacement.
• Quadra System Hip stem system including Quadra-P for primary, Quadra-H for hip revision, with QUADRA-H achieving 13A* exemplary ODEP rating. For orthopedic surgeons.
• Versafitcup Acetabular cup system including Versafitcup CC Trio and Versafitcup DM with double mobility design. For orthopedic surgeons performing hip replacement.
• Mpact System Acetabular implant system for primary and revision hip replacement with 3D metal options. For orthopedic surgeons performing hip replacement.
• Medacta Shoulder System Anatomic and reverse shoulder replacement system for total shoulder arthroplasty, with over 10,000 implants worldwide. For orthopedic surgeons performing shoulder replacement.
• M.U.S.T. Spinal Fixation System Spinal fixation system including M.U.S.T. Mini, M.U.S.T. SI, M.U.S.T. MC, M.U.S.T. Percutaneous, and M.U.S.T. LT variants. For spine surgeons.
• MectaLIF Lumbar interbody fusion system including MectaLIF Anterior and MectaLIF TipEEK for minimally invasive fusion procedures. For spine surgeons.
• Mecta-C Cervical spinal system including Mecta-C Stand Alone and Mecta-C System for cervical disc replacement and fusion. For spine surgeons.
• MyImplant Platform Platform for personalized implant management and tracking for complex hip reconstruction cases. For orthopedic surgeons.
• Parcus Medical Sports Medicine Solutions Acquired U.S. company specializing in sports medicine solutions including suture anchors and fixation devices for sports-related procedures. For orthopedic sports medicine surgeons.
• M-ARS ACL Anterior cruciate ligament reconstruction technique with personalized approaches using quadriceps tendon, bone-tendon-bone, or semi-tendinosus grafts. For sports medicine surgeons.
• MectaCem Bone Cement Bone cement for orthopedic implant fixation. For orthopedic surgeons.
• 3D Metal Implants 3D printed metal implants including cones for revision knee procedures and acetabular augments for hip revision. For orthopedic surgeons.
• SensiTiN Coating Technology Cobalt-free titanium nitride coating technology for implants reducing metal ion release and improving wear characteristics. For orthopedic surgeons.
• Mectagrip Surface Technology Advanced surface technology for improved implant fixation and bone ingrowth. For orthopedic surgeons.

Quantifiable outcome

• Over 500,000 AMIS hip procedures performed worldwide
• +3 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

Partnerships

Seven partnerships are on record, tiered core, flagship and minor.

• Parcus MedicalcoreStrategic or Co-development Partner · 7 March 2025Medacta Group SA acquired Parcus Medical to accelerate expansion in Sportsmed segment, strengthening sports medicine portfolio with comprehensive solutions.
• THINK SurgicalcoreTechnology or Integration · 29 August 2024Medacta entered partnership with THINK Surgical for robotic total knee arthroplasty solution, combining Medacta's GMK implants with THINK Surgical's robotic technology.
• Mighty Oak MedicalcoreTechnology or Integration · 28 August 2024Non-exclusive worldwide license of patents for patient-specific pedicle screw guides. Medacta gained access to Mighty Oak Medical's technology for enhanced spine surgery solutions.
• GeisingerflagshipStrategic or Co-development Partner · 18 March 2019First-Ever Knee Replacement Lifetime Guarantee partnership. Geisinger offers lifetime guarantee on knee replacement costs using Medacta's GMK Sphere implants, demonstrating confidence in product quality.
• Balgrist CARD LtdcoreTechnology or Integration · 2 November 2018Acquisition of Balgrist CARD Ltd to strengthen spine surgery capabilities and expand presence in Switzerland.
• Swiss ClimateminorOthersEnvironmental partnership focused on sustainability initiatives, aligning with Medacta's commitment to environmental responsibility.
• Orthopaedic Research and Education Foundation (OREF)coreStrategic or Co-development Partner5-year commitment to match resident donations to OREF, supporting orthopedic research and education initiatives.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Market position

Weaknesses4 records

Competitive moat6 records

Customer concentration

• Xx.com/medacta
• YouTubeyoutube.com/user/MedactaInternational
• LinkedInlinkedin.com/company/medacta-usa-inc-

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medacta USA, Inc.